glp-1 news today 2025 november The medical cycle was anything but quiet. ⬇️ The Trump administration's significant changes to U.S. healthcare policy dominated headlines in 2025 and comprised many of MedPage Today's most-read stories. In GLP-1 Drugs and Neuroendocrine Cancer:

As of 2026, two oral GLP-1 medications are FDA-approved for weight loss: the once-daily Wegovy pill (oral semaglutide 25 mg) and orforglipron (Foundayo)

GLP-1 medications influence appetite and glucose regulation, but they do not independently preserve muscle mass

Initial research indicates GLP-1RAs may improve wound healing through increased angiogenesis and fibroblast activity, especially in diabetic patients with tissue repair difficulties [27]

Your doctor will monitor you for any serious side effects, especially when you first start taking Foundayo

Every protocol is all-inclusive: clinician review, prescription, compounded medication, and shipping